Balance Sheet for ASLAN Pharmaceuticals Limited (ASLN)

$ 1.88   0.01 (+0.53%) Volume: 58.47k 12:59 PM EST 27-Nov-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 22,203 28,909 50,573 51,556 26,309
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - - 1,290 -
Loans Receivable - - - - -
Other Receivables - - - 13,589 -
Receivables - - - 1,290 -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 69 184 72 89 36
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 22,272 29,092 50,645 52,935 26,346
Land and Improvements - - - - -
Buildings and Improvement 996 488 475 - -
Machinery, Furniture and Equipment 247 313 246 - -
Construction in Progress - - - - -
Fixed Assets, Other - - - 383 86
Fixed Assets, Total 1,243 801 721 383 86
Gross Fixed Assets 1,243 801 721 383 86
Accumulated Depreciation (477) (513) (277) - -
Net Fixed Assets 766 288 444 383 86
Intangibles 3 23,081 84 16 -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 1,078 23,788 689 591 154
Total Assets 23,349 52,881 51,334 53,526 26,500
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 4,726 7,948 5,979 3,790 (974)
Short Term Debt 265 - - - -
Notes Payable - - - - -
Accrued Expenses 393 50 - - -
Accrued Liabilities 393 50 - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - - - 2,925
Total Current Liabilities 5,383 7,998 5,979 3,790 1,951
Long Term Debt 17,631 13,975 9,679 8,307 8,265
Deferred Income Tax - - - - -
Other Non-Current Liabilities 447 290 162 - 52,850
Minority Interest 1,074 - - - -
Capital Lease Obligations 491 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 19,644 14,264 9,841 8,307 61,117
Total Liabilities 25,027 22,263 15,820 12,097 63,068
Preferred Shareholder's Equity - - - - 3
Common Shareholder's Equity (1,677) 30,618 35,513 41,430 (36,572)
Common Par 61,367 51,627 41,514 35,627 6
Additional Paid in Capital 116,496 111,460 84,283 54,978 3,397
Cumulative Translation Adjustments - - - - -
Retained Earnings (179,485) (132,469) (90,283) (48,224) (37,654)
Treasury Stock - - - - -
Other Equity Adjustments (55) - - - -
Total Capitalization 15,954 44,593 45,193 49,736 (28,304)
Total Equity (1,677) 30,618 35,513 41,430 (36,569)
Total Liabilities & Shareholder's Equity 23,349 52,881 51,334 53,526 26,500
Cash Flow (47,066) (42,247) (39,923) (8,775) (13,325)
Working Capital 16,889 21,094 44,666 49,145 24,395
Free Cash Flow (25,806) (62,553) (34,417) (6,022) (11,090)
Invested Capital 15,954 44,593 45,193 49,736 (28,304)
Shares Outstanding - Common Class Only 37,991 32,050 26,026 - -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 189,955 160,249 130,129 130,129 130,129
Total Common Shares Outstanding 37,991 32,050 26,026 - -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 32,479 29,948 24,885 105,153 55,909
Diluted Weighted Shares Outstanding 32,479 29,948 24,885 115,635 55,909